Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri scMRD Assay for AML. Learn More
X
Scientific presentation

AML Single-cell Multi-omics MRD (scMRD) and the Horizon of Clinical Utility


Aaron Llanso
Description

The Tapestri Single-cell Multi-omics MRD (scMRD) Assay for AML provides institutions early access to our scMRD technology, which allows for MRD detection with unparalleled resolution, sensitivity, and specificity. At this year’s AMP Annual Meeting & Expo, Aaron Llanso shared how the scMRD technology can be leveraged to improve the identification of residual disease and potential therapeutic strategies, including an overview of scMRD data. He also discussed opportunities for single-cell multi-omics in the clinic for MRD and beyond, and provided an insider look into our scMRD Early Access Program



VIEW


Scientific presentation
Molecular Analysis of Acute Myeloid Leukemia in Morphologic Remission
Sanam Loghavi, MD
AMP 2022 (2022)
Scientific presentation
Considerations, Strategies, and Advances in Early Drug Development to Mitigate Clinical Holds and Achieve Successful CGT Outcomes
Azadeh Golipour, PhD, AVROBIO
J. Kelly Ganjei, AmplifyBio
Scott R. Burger, MD, Advanced Cell and Gene Therapy
Matthew Cato
(2022)
Scientific presentation
Overview on Mission Bio’s Applications
Simone Formisano
Mission Bio EU Heme Symposium (2022)
Scientific presentation
Single Cell Core Facility Services at Josep Carreras Institute
Caterina Mata Garcia, PhD
Mission Bio EU Heme Symposium (2022)
REQUEST QUOTE